# US 2017/0281545 A1 · Immunomodulation Using Spores and Pollen Grains

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281545 A1
- Document ID: US20170281545A1
- Status: Published application
- Kind: A1
- Application number: 15/627,489
- Filed: 2017-06-20
- Published: 2017-10-05
- Earliest claimed: 2012-10-15
- Assignees: Texas Tech University System
- Applicants: Texas Tech University System
- Inventors: Harvinder S. Gill; Shashwati Atwe; Yunzhe Ma
- Web page: https://patentgrep.com/patent/US20170281545A1

## CPC

- A61K 9/167: {with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface (with further drug-free outer coating A61K9/5073)}
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- A61K 39/07: Bacillus
- A61K 39/12: Viral antigens
- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61P 37/02: Immunomodulators
- A61K 2039/542: {oral/gastrointestinal}
- A61K 2039/55588: {Adjuvants of undefined constitution}
- C12N 2740/16034: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention includes compositions, methods of making and using the compositions for modulating the immune response in a subject by providing a vaccine composition having a pollen or spore disposed in a pharmaceutical carrier for delivery to a subject, wherein the pollen or spore comprises multiple pores that connect an outer surface of the pollen/spore to an inner cavity and one or more antigens disposed on the outer surface, in the inner cavity, in the multiple pores, or a combination thereof, wherein the one or more antigens modulate an immune responses in the subject.

## Claims

### Claim 1

A method of modulating the immune response in a subject comprising the steps of:
providing an immunogenic composition comprising:
one or more antigens in, on, or about a pollen or spore, wherein the pollen or spore has been cleaned to eliminate any plant proteins, disposed in a pharmaceutical carrier for delivery to a subject; and
administering the composition to the subject to modulate an immune responses.

### Claim 2 (depends on 1)

The method of claim 1, wherein the immune response targets at least one of: a bacteria, a virus, a fungi, a protozoan, a parasite, a prion, a toxin, a cancer, an allergy, or an auto-immune diseases.

### Claim 3 (depends on 1)

The method of claim 1, wherein the one or more antigens is selected from at least one of:
oligonucleotides, proteins, peptides, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), cells (broken or intact), lipids, toxin variants, carbohydrates, virus-like particles, liposomes, live attenuated or killed natural or recombinant microorganisms, bacteria, viruses, and particulate vaccine delivery systems, liposomes, virosomes, polymeric/inorganic/organic micro and nanoparticles, or immune stimulating complexes (ISCOMS).

### Claim 4 (depends on 1)

The method of claim 1, wherein the immunogenic composition is delivered orally, nasally, through pulmonary route, through rectal route, through eyes, through skin or its appendages, through ears, through vaginal route, through injection into various tissues or into blood in a liquid, a solid, an aerosolized or a combination thereof.

### Claim 5 (depends on 1)

The method of claim 1, further comprising a polymer or hydrogel coating applied to the pollen or spore, wherein the polymer coating is a diffusion barrier, and/or a coating that includes physical or chemical adsorption/attachment/anchoring points, plugs one or more of the multiple pores, coats or fills the inner cavity and/or coats the exterior surface of the pollen or spore fully or partially or a combination thereof, and wherein the polymer applied to the pollen or spore comprises anchoring points are polymeric/inorganic/organic macro, micro and nanoparticles.

### Claim 6 (depends on 1)

The method of claim 1, wherein antigen is at least one of attached, adsorbed, or anchored physically or chemically to the particles.

### Claim 7 (depends on 1)

The method of claim 1, further comprising one or more adjuvants, wherein the adjuvants are selected from particles on the outer surface, in the inner cavity, or pores of the pollen or spores or combinations thereof, wherein the particles are polymeric/inorganic/organic macro, micro and nanoparticles, alum-based particles including aluminum hydroxide, aluminum phosphate, or gold particles or iron particles or iron oxide particles or combinations thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein one or more antigens increase or decrease the immune responses in the subject.

### Claim 9 (depends on 1)

The method of claim 1, wherein the pollen or spore is a fragment of a pollen or spore.

### Claim 10 (depends on 7)

The method of claim 7, wherein the one or more adjuvants is a cytokine, chemokine, toll-like receptor ligands or activators, CpG, alum, muramyl dipeptides, pyridine, chitosan, gardiquimod, imiquimod, saponins, oils, emulsions, Amphigen, Lipopolysaccharide, bacterial cell wall extracts, bacterial proteins, bacterial DNA or mimics, viral RNA or mimics, synthetic oligonucleotides, and combinations thereof.

### Claim 11

A method of modulating an immune response in a subject comprising the steps of:
providing an immunogenic composition comprising:
a pollen or a spore in a pharmaceutical carrier for delivery to a subject, wherein the pollen or spore comprises multiple pores; and
one or more antigens, wherein the one or more antigens increase or decrease an immune responses in the subject; and
administering the vaccine composition to the subject to modulate the immune responses.

### Claim 12 (depends on 11)

The method of claim 11, wherein the one or more antigens is a cytokine, chemokine, toll-like receptor ligands or activators, CpG, alum, muramyl dipeptides, pyridine, chitosan, gardiquimod, imiquimod, saponins, oils, emulsions, Amphigen, Lipopolysaccharide, bacterial cell wall extracts, bacterial proteins, bacterial DNA or mimics, viral RNA or mimics, synthetic oligonucleotides, and combinations thereof.

### Claim 13 (depends on 11)

The method of claim 11, wherein the vaccine composition is delivered orally, nasally, through pulmonary route, through rectal route, through eyes, through skin or its appendages, through ears, through vaginal route, through injection into various tissues or into blood by any means.

### Claim 14 (depends on 11)

The method of claim 11, wherein the immunogenic composition is a liquid, a solid, an aerosolized or a combination thereof.

### Claim 15 (depends on 11)

The method of claim 11, wherein the one or more antigens are suspended in composition, or deposited, physically attached, bound, adsorbed, chemically linked to pollen or spores or a combination thereof.

### Claim 16 (depends on 11)

The method of claim 11, further comprising a polymer or hydrogel coating applied to the pollen or spore, wherein the polymer coating is a diffusion barrier, and/or a coating that includes physical or chemical adsorption/attachment/anchoring points, plugs one or more of the multiple pores, coats or fills the inner cavity and/or the exterior surface of the pollen or spore fully or partially or a combination thereof.

### Claim 17 (depends on 11)

The method of claim 11, further comprising one or more particles on the outer surface, in the inner cavity, or pores of the pollen or spores or combinations thereof, wherein the particles are polymeric/inorganic/organic macro, micro and nanoparticles.

### Claim 18 (depends on 17)

The method of claim 17, wherein particles are alum-based particles including aluminum hydroxide, aluminum phosphate, or gold particles or iron particles or iron oxide particles or combinations thereof.

### Claim 19

A method of modulating the immune response in a subject comprising the steps of:
providing a composition comprising one or more antigens and at least one of an intact or fragment of a pollen or spore that is free of pollen or spore antigens, in an amount sufficient to trigger an immune response disposed in a pharmaceutical carrier for delivery to the subject, wherein the pollen/pollen spore comprises multiple pores; and
administering the composition to the subject to modulate an immune responses.

### Claim 20 (depends on 19)

The method of claim 19, wherein the one or more antigens are selected from at least one of bacteria, viruses, fungi, protozoans, parasites, prions, toxins, cancer, allergens, and auto-immune antigens.

### Claim 21 (depends on 19)

The method of claim 19, wherein the one or more antigens are selected from at least of oa:
oligonucleotides, proteins, peptides, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), cells (broken or intact), lipids, toxin variants, carbohydrates, virus-like particles, liposomes, live attenuated or killed natural or recombinant microorganisms, bacteria, viruses, and particulate vaccine delivery systems, liposomes, virosomes, polymeric/inorganic/organic micro and nanoparticles, immune stimulating complexes (ISCOMS) and combinations thereof, and wherein antigens are at least one of: in composition with, attached, adsorbed, anchored physically, or anchored chemically, to pollen or spore at at least one of an exterior surface, an interior surface, a cavity or a pore of the pollen or spore.

### Claim 22 (depends on 19)

The method of claim 19, wherein the composition is delivered orally, nasally, through pulmonary route, through rectal route, through eyes, through skin or its appendages, through ears, through vaginal route, through injection into various tissues or into blood.

### Claim 23 (depends on 19)

The method of claim 19, further comprising the step of providing the subject with one or more compositions that neutralize gastric acid selected from at least one of before, during or after immunization.

### Claim 24 (depends on 19)

The method of claim 19, wherein the composition is provided without neutralizing gastric acid selected from at least one of before, during or after immunization.

### Claim 25 (depends on 19)

The method of claim 19, wherein the composition further comprise an agent that activates at least one of B cell, T cell, a Natural Killer cell, an adaptive immune response, or an innate immune response.

### Claim 26

A composition comprising
an intact or fragment of pollen or spore that is free of pollen or spore antigens disposed in a pharmaceutical carrier for delivery to a subject; and
one or more antigens, wherein the composition triggers an immune response that is specific to the one or more antigens.

### Claim 27 (depends on 26)

The composition of claim 26, wherein modulation is to wards infectious agents including bacteria, viruses, fungi, protozoans, parasites, prions, toxins, cancer, allergies, and various auto-immune diseases.

### Claim 28 (depends on 26)

The composition of claim 26, wherein the one or more antigens are selected from at least one of: oligonucleotides, proteins, peptides, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), cells (broken or intact), lipids, toxin variants, carbohydrates, virus-like particles, liposomes, live attenuated or killed natural or recombinant microorganisms, bacteria, viruses, and particulate vaccine delivery systems, liposomes, virosomes, polymeric/inorganic/organic micro and nanoparticles, immune stimulating complexes (ISCOMS) and combinations thereof,

### Claim 29 (depends on 26)

The composition of claim 26, wherein the one or more antigens are at least one of: attached, adsorbed, anchored physically, or anchored chemically, to the pollen or spore.

### Claim 30 (depends on 26)

The composition of claim 26, wherein the one or more antigens are in at least one of: an exterior surface, an interior surface, a cavity, or a pore of the pollen or spore.

### Claim 31 (depends on 26)

The composition of claim 26, wherein the composition is adapted for oral, nasal, pulmonary, rectal route, optical, subcutaneous, vaginal, or via injection into various tissues or into blood.
